Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.325 USD | -3.93% | -10.04% | +3.39% |
02:01pm | Standard BioTools Inc. Announces Operational Restructuring Plan | CI |
Apr. 16 | TD Cowen Starts Standard BioTools With Buy Rating, $3.50 Price Target | MT |
Business Summary
Number of employees: 537
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Consumables
39.3
%
| 47 | 47.8 % | 42 | 39.3 % | -10.80% |
Instruments
35.2
%
| 26 | 26.2 % | 37 | 35.2 % | +45.96% |
Service
24.4
%
| 24 | 24.2 % | 26 | 24.4 % | +9.56% |
Other
1.1
%
| - | - | 1 | 1.1 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
41.5
%
| 41 | 41.9 % | 44 | 41.5 % | +7.56% |
EMEA
34.0
%
| 33 | 33.8 % | 36 | 34.0 % | +9.25% |
China
14.9
%
| 11 | 11.5 % | 16 | 14.9 % | +39.82% |
Asia-Pacific
7.7
%
| 10 | 9.7 % | 8 | 7.7 % | -14.55% |
Americas
2.0
%
| 3 | 3.0 % | 2 | 2.0 % | -29.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 23-05-14 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | Jan. 04 |
Hanjoon Kim
COO | Chief Operating Officer | 53 | 22-04-03 |
Jeremy Davis
PRN | Corporate Officer/Principal | - | 22-06-11 |
Adam Taich
PRN | Corporate Officer/Principal | 49 | Jan. 04 |
Elizabeth Jensen
HRO | Human Resources Officer | 50 | 23-01-02 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 22-03-31 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 23-03-14 |
Kathy Hibbs
BRD | Director/Board Member | 60 | Jan. 04 |
Michael Egholm
CEO | Chief Executive Officer | 61 | 22-04-03 |
Eli Casdin
BRD | Director/Board Member | 51 | 22-04-03 |
Troy Cox
BRD | Director/Board Member | 60 | Jan. 04 |
Thomas Carey
CHM | Chairman | 62 | Jan. 04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 293,249,930 | 287,216,751 ( 97.94 %) | 3,132,000 ( 1.068 %) | 97.94 % |
Company contact information
Standard BioTools, Inc.
2 Tower Place Suite 2000
94080, South San Francisco
+650 266 6000
http://www.standardbio.comSector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.39% | 926M | |
+7.93% | 220B | |
+6.17% | 185B | |
+9.11% | 133B | |
+26.58% | 107B | |
-0.27% | 62.91B | |
+13.78% | 53.34B | |
-1.63% | 47.71B | |
-3.04% | 40.29B | |
+9.71% | 39.57B |
- Stock Market
- Equities
- LAB Stock
- Company Standard BioTools Inc.